1
A patient with LDL-C 120 mg/dL and ASCVD risk 12% is started on atorvastatin 80 mg. When should LFTs be rechecked?
cardiovascular system
dyslipidemia MCQs
Progress
0
/
6
2
Why is it important to assess for drug interactions with simvastatin and lovastatin?
3
A 48-year-old woman with LDL-C 150 mg/dL and ASCVD risk 11% is started on rosuvastatin 20 mg. What is the secondary lipid goal?
4
A patient with LDL-C 90 mg/dL and ASCVD on maximal statin and ezetimibe asks about further LDL lowering. Which injectable therapy is most effective?
5
What is the main reason for checking creatine kinase (CK) in statin-treated patients?
6
A 54-year-old man with LDL-C 130 mg/dL and ASCVD risk 9% is started on atorvastatin 80 mg. What is the primary monitoring parameter?
❔ Something feels off? Tap the question icon at the top of the question to raise an issue.
If it’s wrong, unclear, duplicated, or showing up too often, let us know.
Sometimes it’s a real issue. Sometimes you're just getting cooked 🍳🔥 — we’ll review it ASAP.
